Analysis of the risk and pre-emptive control of viral outbreaks accounting for within-host dynamics : SARS-CoV-2 as a case study

In the era of living with COVID-19, the risk of localised SARS-CoV-2 outbreaks remains. Here, we develop a multiscale modelling framework for estimating the local outbreak risk for a viral disease (the probability that a major outbreak results from a single case introduced into the population), accounting for within-host viral dynamics. Compared to population-level models previously used to estimate outbreak risks, our approach enables more detailed analysis of how the risk can be mitigated through pre-emptive interventions such as antigen testing. Considering SARS-CoV-2 as a case study, we quantify the within-host dynamics using data from individuals with omicron variant infections. We demonstrate that regular antigen testing reduces, but may not eliminate, the outbreak risk, depending on characteristics of local transmission. In our baseline analysis, daily antigen testing reduces the outbreak risk by 45% compared to a scenario without antigen testing. Additionally, we show that accounting for heterogeneity in within-host dynamics between individuals affects outbreak risk estimates and assessments of the impact of antigen testing. Our results therefore highlight important factors to consider when using multiscale models to design pre-emptive interventions against SARS-CoV-2 and other viruses.

Medienart:

E-Artikel

Erscheinungsjahr:

2023

Erschienen:

2023

Enthalten in:

Zur Gesamtaufnahme - volume:120

Enthalten in:

Proceedings of the National Academy of Sciences of the United States of America - 120(2023), 41 vom: 10. Okt., Seite e2305451120

Sprache:

Englisch

Beteiligte Personen:

Hart, William S [VerfasserIn]
Park, Hyeongki [VerfasserIn]
Jeong, Yong Dam [VerfasserIn]
Kim, Kwang Su [VerfasserIn]
Yoshimura, Raiki [VerfasserIn]
Thompson, Robin N [VerfasserIn]
Iwami, Shingo [VerfasserIn]

Links:

Volltext

Themen:

Antigen testing
COVID-19
Infectious disease modelling
Journal Article
Outbreak risk
Research Support, Non-U.S. Gov't
SARS-CoV-2

Anmerkungen:

Date Completed 05.10.2023

Date Revised 17.10.2023

published: Print-Electronic

Citation Status MEDLINE

doi:

10.1073/pnas.2305451120

funding:

Förderinstitution / Projekttitel:

PPN (Katalog-ID):

NLM362820902